<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00448526</url>
  </required_header>
  <id_info>
    <org_study_id>H8-H-077</org_study_id>
    <nct_id>NCT00448526</nct_id>
  </id_info>
  <brief_title>Effect of Low Protein Diet in Preventing the Progression of Diabetic Nephropathy</brief_title>
  <acronym>LPD</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Kanazawa Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanazawa Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetic nephropathy is the leading cause of chronic kidney disease all the world in spite of&#xD;
      progress in new treatment for diabetes and anti hypertensive drugs. Additional treatments are&#xD;
      thus needed to arrest the progression of diabetic nephropathy. Although there is insufficient&#xD;
      evidence to suggest that a low-protein diet improves renal dysfunction, it is recommended as&#xD;
      a mainstay of nutritional management. We here assessed the role of low protein diet in renal&#xD;
      function as well as albuminuria in type 2 diabetic patients with nephropathy for a median of&#xD;
      5 years.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Terminated: recruiting or enrolling participants has halted and will not resume because low&#xD;
    protein diet is not feasible nor efficious.&#xD;
  </why_stopped>
  <start_date>December 1997</start_date>
  <completion_date>August 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>annual change of GFR</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>annual change of Ccr</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>annual change of 1/Cr</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>incidence rate of the doubling of sCr</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>time to the doubling of sCr</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>urinary albumin and protein excretion</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% change of urinary albumin and protein excretion from baseline</measure>
  </secondary_outcome>
  <condition>Diabetic Nephropathies</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>low protein diet</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 2 diabetes mellitus&#xD;
&#xD;
          -  Urinary protein excretion 1-10 g/day&#xD;
&#xD;
          -  Serum Cr &lt;2.0 mg/dl&#xD;
&#xD;
          -  With diabetic retinopathy &gt; SDR&#xD;
&#xD;
          -  Normal protein intake instruction&#xD;
&#xD;
          -  Patients whose consent is obtained at &gt;20 or age =&lt;65&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Type 1 Diabetes Mellitus&#xD;
&#xD;
          -  Non-diabetic nephropathy&#xD;
&#xD;
          -  Urinary tract infection&#xD;
&#xD;
          -  Congestive heart failure&#xD;
&#xD;
          -  Unstable angina&#xD;
&#xD;
          -  Myocardial infarction&#xD;
&#xD;
          -  Stroke&#xD;
&#xD;
          -  Severe hepatopathy&#xD;
&#xD;
          -  Life threatening disease such as malignant tumor&#xD;
&#xD;
          -  Patients on ACE-I and or ARB treatment&#xD;
&#xD;
          -  Patients on instruction of low protein diet&#xD;
&#xD;
          -  BW&lt; 80% of IBW&#xD;
&#xD;
          -  Pregnant, lactating, and probably pregnant patients&#xD;
&#xD;
          -  Patients judged as being inappropriate fir the subjects&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Ryuichi Kikkawa, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Shiga University of Medical Science</affiliation>
  </overall_official>
  <verification_date>March 2007</verification_date>
  <study_first_submitted>March 16, 2007</study_first_submitted>
  <study_first_submitted_qc>March 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2007</study_first_posted>
  <last_update_submitted>March 16, 2007</last_update_submitted>
  <last_update_submitted_qc>March 16, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2007</last_update_posted>
  <keyword>Low protein diet, type 2 Diabetic nephropathy</keyword>
  <keyword>Comparing the effect of Low protein Diet on diabetic nephropathy to that of normal protein diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Diabetic Nephropathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

